Get started
Keyword

ezetimibe

Description: A cholesterol-lowering drug that reduces intestinal absorption of cholesterol and is used to treat elevated blood lipid levels.
Wikidata ID: wiki/Q417997
OpenAlex ID: keywords/ezetimibe
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 · Scott M. Grundy, Neil J. Stone, et al. · Circulation · 6,189
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
2015 · Christopher P. Cannon, Michael A. Blazing, et al. · New England Journal of Medicine · 4,492
PDF
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
2011 · The AIM-HIGH Investigators · New England Journal of Medicine · 2,929
PDF
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
2013 · B. G. Nordestgaard, M. J. Chapman, et al. · European Heart Journal · 2,770
PDF
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
2018 · Scott M. Grundy, Neil J. Stone, et al. · Journal of the American College of Cardiology · 2,685
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
2011 · Colin Baigent, Martin J Landray, et al. · The Lancet · 2,481
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 · Sidney C. Smith, Jerilyn Allen, et al. · Circulation · 2,105
PDF
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
2004 · Scott W. Altmann, Harry R. Davis, et al. · Science · 1,783
Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
2008 · Anne B. Rossebø, Terje R. Pedersen, et al. · New England Journal of Medicine · 1,646
PDF
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
2016 · Michael G. Silverman, Brian A. Ference, et al. · JAMA · 1,485
PDF
Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
2009 · Pia R. Kamstrup · JAMA · 1,358
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
2008 · John J.P. Kastelein, Fatima Akdim, et al. · New England Journal of Medicine · 1,240
PDF
American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease
2017 · Paul S. Jellinger, Yehuda Handelsman, et al. · Endocrine Practice · 1,091
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
2014 · M. Cuchel, E. Bruckert, et al. · European Heart Journal · 1,061
PDF
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 · Scott M. Grundy, Neil J. Stone, et al. · Circulation · 907
PDF
Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
2008 · Steven E. Nissen, Stephen J. Nicholls, et al. · JAMA · 851
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study
2020 · Kausik K Ray, Bart Molemans, et al. · European Journal of Preventive Cardiology · 836
PDF
The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)
2005 · Margarita Garcia-Calvo, JeanMarie Lisnock, et al. · Proceedings of the National Academy of Sciences · 771
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
2014 · Frederick J Raal, Evan A Stein, et al. · The Lancet · 757
A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
2014 · Dirk J. Blom, Tomas Hala, et al. · New England Journal of Medicine · 723
PDF
Niemann-Pick C1 Like 1 (NPC1L1) Is the Intestinal Phytosterol and Cholesterol Transporter and a Key Modulator of Whole-body Cholesterol Homeostasis
2004 · Harry R. Davis, Li-ji Zhu, et al. · Journal of Biological Chemistry · 699
PDF
Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia
2003 · Christie M. Ballantyne, John Houri, et al. · Circulation · 688
Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans
2002 · Thomas Sudhop, Dieter Lütjohann, et al. · Circulation · 684
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
2013 · HPS2-THRIVE Collaborative Group, R. Haynes, et al. · European Heart Journal · 677
PDF
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient
2014 · Christoph Wanner, the Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members, et al. · Kidney International · 649
Works count: 11,150
Citation count: 197,100
Year
Topic
Type